MedinCell announces the transfer of its shares from compartment C to compartment B of Euronext Paris
January 28, 2021
Previous PostTeva and MedinCell Announce Positive Results for Registration Trial of Investigational Extended-Release Subcutaneous Injectable Risperidone for Patients with Schizophrenia
Next PostPublication of the 2021 financial calendar
